San Antonio, Texas (September 26, 2019) - In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more ...
News
- Texas Biomed continues testing Ebola therapies and vaccines
- Investigational Drug with Immunotherapy May Provide New Therapeutic Opportunity for Patients ...
... the START Center for Cancer Care, San Antonio; Memorial Sloan Kettering Cancer Center, New York; ARMO Biosciences, Redwood City, Calif.; ...
- UNR sells slice of half-century-old research farm for $18M
RENO, Nev. (AP) — The University of Nevada, Reno has completed the $18 million sale of about one-tenth of its half-century-old research farm for ...
- StemBioSys chairwoman earns national honor for work in bioscience
The Advanced Medical Technology Association — based in Washington, D.C. — will honor San Antonio bioscience leader Cathy Burzik on ...
- Digerati Technologies to Acquire Nexogy, Inc. and Double Annual Revenue to $13 Million
SAN ANTONIO, Texas, Sept. 24, 2019 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of ...